18^th Global Pharmacovigilance & Clinical Trials Summit

Pharmacovigilance focuses on the systematic monitoring, detection, assessment, and prevention of adverse effects associated with medicines. This track explores safety data collection, individual case safety reports, signal management, and risk evaluation. It also covers innovative approaches for strengthening medicine safety throughout the product lifecycle. Researchers can present new strategies for improving global pharmacovigilance practices and patient protection.

Clinical Trials focuses on the design, management, conduct, and evaluation of clinical studies. Topics include innovative trial designs, patient recruitment, clinical endpoints, trial monitoring, safety assessment, and data quality. The session explores modern approaches for improving trial efficiency, transparency, and patient participation. Researchers can share developments that support faster, safer, and more reliable clinical research.

Drug Safety focuses on identifying, evaluating, monitoring, and managing potential risks associated with pharmaceutical products. This track covers adverse events, medication errors, safety assessments, benefit-risk evaluation, and safety communication. It explores strategies for detecting potential safety concerns at different stages of drug development. The session emphasizes patient protection and the responsible use of medicines.

Risk Management explores systematic approaches for identifying, evaluating, controlling, and minimizing risks associated with medicines. Topics include risk management plans, risk minimization measures, safety concerns, benefit-risk assessment, and regulatory expectations. The session highlights proactive methods for managing known and potential risks. Researchers can discuss innovative approaches to improving pharmaceutical risk management.

Signal Detection focuses on identifying potential new safety concerns from clinical, spontaneous reporting, and real-world data sources. This track covers data mining, statistical analysis, signal validation, prioritization, and evaluation. Advanced technologies such as artificial intelligence and machine learning will also be explored. The session highlights methods for improving the accuracy and efficiency of safety-signal identification.

Clinical Research explores scientific approaches for evaluating medicines, therapies, and healthcare interventions. This track covers research methodologies, clinical study design, translational research, patient-centered research, clinical outcomes, and research ethics. It provides a platform for sharing innovative research findings and practical experiences. The session emphasizes improving the quality, reliability, and impact of clinical research.

Regulatory Affairs focuses on the regulatory frameworks governing clinical trials, medicines, and pharmacovigilance activities. Topics include regulatory submissions, international guidelines, compliance requirements, inspections, safety documentation, and regulatory strategies. The track examines evolving global regulatory expectations and challenges. Participants can discuss approaches for maintaining compliance throughout the drug development lifecycle.

Real-World Evidence explores the use of real-world data to evaluate the safety, effectiveness, and utilization of medicines. This track includes electronic health records, patient registries, observational studies, healthcare databases, and post-authorization research. Researchers can present innovative approaches for generating meaningful evidence outside traditional clinical trials. The session highlights the growing role of real-world evidence in healthcare and regulatory decision-making.

Safety Analytics focuses on applying statistical methods, data science, and advanced technologies to pharmaceutical safety information. Topics include predictive analytics, safety databases, data visualization, automated reporting, and large-scale safety-data analysis. The session explores methods for identifying patterns and emerging safety concerns. Researchers can present innovative analytical approaches for supporting evidence-based safety decisions.

Digital Health explores the use of digital technologies in clinical research, pharmacovigilance, and patient safety. This track covers mobile health, wearable devices, remote monitoring, electronic health systems, digital therapeutics, and virtual healthcare. Discussions will focus on how digital solutions can improve data collection, patient engagement, and safety monitoring. The session highlights emerging technologies transforming modern clinical research.

Artificial Intelligence focuses on the application of AI and machine learning in pharmacovigilance and clinical research. Topics include automated case processing, natural language processing, signal detection, predictive safety analytics, data classification, and intelligent decision-support systems. The track explores opportunities to improve efficiency and reduce manual processes. It also addresses data quality, transparency, validation, ethics, and regulatory considerations.

Clinical Data focuses on the collection, organization, management, validation, and analysis of information generated during clinical studies. This track covers electronic data capture, clinical databases, data standards, data quality, data integrity, and data-management technologies. Researchers can discuss strategies for improving the reliability and accessibility of clinical information. The session highlights the importance of high-quality data in successful clinical research.

Patient Safety focuses on preventing medication-related harm and improving healthcare quality and outcomes. Topics include medication errors, adverse events, patient reporting, safety communication, adherence, and patient involvement in safety monitoring. The session promotes patient-centered approaches to medicine safety. Researchers can explore innovative strategies for strengthening patient participation and reducing preventable risks.

Safety Surveillance focuses on continuous monitoring of medicines and medical products throughout their lifecycle. This track covers post-marketing surveillance, adverse-event monitoring, epidemiological studies, long-term safety assessment, and safety databases. Researchers can discuss methods for identifying emerging risks and evaluating safety trends. The session highlights the importance of continuous monitoring in protecting patients and maintaining confidence in medicines.